Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure

Piyaparisorn Wongvaranon, Varisa Pongrakhananon, Preedakorn Chunhacha, Pithi Chanvorachote

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: The effect of extended exposure of cancer cells to nitric oxide (NO), an endogenous mediator frequently found increased in tumors, is largely unknown. In the present study, the effect of long-term NO exposure on chemotherapeutic resistance was investigated in lung cancer cells. Materials and Methods: The effect of long-term exposure of human lung cancer cells to NO on susceptibility to chemotherapeutic agents-induced apoptosis was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, co-staining of Hoechst 33342 and propidium iodide (PI), and Annexin V detection. The expression of survival-related proteins was analyzed by western blot. Gene manipulation was used for evaluation of the effect of expression proteins on susceptibility of the cells to chemotherapeutic agent-mediated death. Results: Long-term NO exposure for 7-14 days rendered the lung cancer cells resistant to cisplatin, doxorubicin, and etoposide dose- and time-dependently. The underlying mechanism was found to involve the adaptive responses of the cells, by increasing survival due to increase in the level of caveolin-1 (CAV1) and anti-apoptotic B-cell lymphoma-2 (BCL2), and up-regulation of activated protein kinase B (AKT). The gene manipulation study revealed that the increase of activated AKT and BCL2 was responsible for the resistance to all tested drugs, while the up-regulation of CAV1 only attenuated cell death mediated by doxorubicin and etoposide. Interestingly, NO-mediated drug resistance was found to be reversible when cells were further cultured in the absence of NO for five days. Conclusion: These findings reveal the novel role of NO in the tumor environment, in attenuating chemotherapeutic susceptibility and this could be beneficial in contriving strategies to treat the disease.

Original languageEnglish (US)
Pages (from-to)5433-5444
Number of pages12
JournalAnticancer Research
Volume33
Issue number12
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Lung Neoplasms
Nitric Oxide
Drug Therapy
Caveolin 1
B-Cell Lymphoma
Etoposide
Doxorubicin
Up-Regulation
Neoplasms
Proto-Oncogene Proteins c-akt
Propidium
Annexin A5
Drug Resistance
Cisplatin
Genes
Cell Survival
Proteins
Cell Death
Western Blotting
Apoptosis

Keywords

  • Chemotherapeutic resistance
  • Cisplatin
  • Doxorubicin
  • Etoposide
  • Lung cancer
  • Nitric oxide

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wongvaranon, P., Pongrakhananon, V., Chunhacha, P., & Chanvorachote, P. (2013). Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Research, 33(12), 5433-5444.

Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. / Wongvaranon, Piyaparisorn; Pongrakhananon, Varisa; Chunhacha, Preedakorn; Chanvorachote, Pithi.

In: Anticancer Research, Vol. 33, No. 12, 12.2013, p. 5433-5444.

Research output: Contribution to journalArticle

Wongvaranon, P, Pongrakhananon, V, Chunhacha, P & Chanvorachote, P 2013, 'Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure', Anticancer Research, vol. 33, no. 12, pp. 5433-5444.
Wongvaranon P, Pongrakhananon V, Chunhacha P, Chanvorachote P. Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Research. 2013 Dec;33(12):5433-5444.
Wongvaranon, Piyaparisorn ; Pongrakhananon, Varisa ; Chunhacha, Preedakorn ; Chanvorachote, Pithi. / Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. In: Anticancer Research. 2013 ; Vol. 33, No. 12. pp. 5433-5444.
@article{8d9b74fc1caf42d6aa22d78ac490afb5,
title = "Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure",
abstract = "Background: The effect of extended exposure of cancer cells to nitric oxide (NO), an endogenous mediator frequently found increased in tumors, is largely unknown. In the present study, the effect of long-term NO exposure on chemotherapeutic resistance was investigated in lung cancer cells. Materials and Methods: The effect of long-term exposure of human lung cancer cells to NO on susceptibility to chemotherapeutic agents-induced apoptosis was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, co-staining of Hoechst 33342 and propidium iodide (PI), and Annexin V detection. The expression of survival-related proteins was analyzed by western blot. Gene manipulation was used for evaluation of the effect of expression proteins on susceptibility of the cells to chemotherapeutic agent-mediated death. Results: Long-term NO exposure for 7-14 days rendered the lung cancer cells resistant to cisplatin, doxorubicin, and etoposide dose- and time-dependently. The underlying mechanism was found to involve the adaptive responses of the cells, by increasing survival due to increase in the level of caveolin-1 (CAV1) and anti-apoptotic B-cell lymphoma-2 (BCL2), and up-regulation of activated protein kinase B (AKT). The gene manipulation study revealed that the increase of activated AKT and BCL2 was responsible for the resistance to all tested drugs, while the up-regulation of CAV1 only attenuated cell death mediated by doxorubicin and etoposide. Interestingly, NO-mediated drug resistance was found to be reversible when cells were further cultured in the absence of NO for five days. Conclusion: These findings reveal the novel role of NO in the tumor environment, in attenuating chemotherapeutic susceptibility and this could be beneficial in contriving strategies to treat the disease.",
keywords = "Chemotherapeutic resistance, Cisplatin, Doxorubicin, Etoposide, Lung cancer, Nitric oxide",
author = "Piyaparisorn Wongvaranon and Varisa Pongrakhananon and Preedakorn Chunhacha and Pithi Chanvorachote",
year = "2013",
month = "12",
language = "English (US)",
volume = "33",
pages = "5433--5444",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

TY - JOUR

T1 - Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure

AU - Wongvaranon, Piyaparisorn

AU - Pongrakhananon, Varisa

AU - Chunhacha, Preedakorn

AU - Chanvorachote, Pithi

PY - 2013/12

Y1 - 2013/12

N2 - Background: The effect of extended exposure of cancer cells to nitric oxide (NO), an endogenous mediator frequently found increased in tumors, is largely unknown. In the present study, the effect of long-term NO exposure on chemotherapeutic resistance was investigated in lung cancer cells. Materials and Methods: The effect of long-term exposure of human lung cancer cells to NO on susceptibility to chemotherapeutic agents-induced apoptosis was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, co-staining of Hoechst 33342 and propidium iodide (PI), and Annexin V detection. The expression of survival-related proteins was analyzed by western blot. Gene manipulation was used for evaluation of the effect of expression proteins on susceptibility of the cells to chemotherapeutic agent-mediated death. Results: Long-term NO exposure for 7-14 days rendered the lung cancer cells resistant to cisplatin, doxorubicin, and etoposide dose- and time-dependently. The underlying mechanism was found to involve the adaptive responses of the cells, by increasing survival due to increase in the level of caveolin-1 (CAV1) and anti-apoptotic B-cell lymphoma-2 (BCL2), and up-regulation of activated protein kinase B (AKT). The gene manipulation study revealed that the increase of activated AKT and BCL2 was responsible for the resistance to all tested drugs, while the up-regulation of CAV1 only attenuated cell death mediated by doxorubicin and etoposide. Interestingly, NO-mediated drug resistance was found to be reversible when cells were further cultured in the absence of NO for five days. Conclusion: These findings reveal the novel role of NO in the tumor environment, in attenuating chemotherapeutic susceptibility and this could be beneficial in contriving strategies to treat the disease.

AB - Background: The effect of extended exposure of cancer cells to nitric oxide (NO), an endogenous mediator frequently found increased in tumors, is largely unknown. In the present study, the effect of long-term NO exposure on chemotherapeutic resistance was investigated in lung cancer cells. Materials and Methods: The effect of long-term exposure of human lung cancer cells to NO on susceptibility to chemotherapeutic agents-induced apoptosis was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, co-staining of Hoechst 33342 and propidium iodide (PI), and Annexin V detection. The expression of survival-related proteins was analyzed by western blot. Gene manipulation was used for evaluation of the effect of expression proteins on susceptibility of the cells to chemotherapeutic agent-mediated death. Results: Long-term NO exposure for 7-14 days rendered the lung cancer cells resistant to cisplatin, doxorubicin, and etoposide dose- and time-dependently. The underlying mechanism was found to involve the adaptive responses of the cells, by increasing survival due to increase in the level of caveolin-1 (CAV1) and anti-apoptotic B-cell lymphoma-2 (BCL2), and up-regulation of activated protein kinase B (AKT). The gene manipulation study revealed that the increase of activated AKT and BCL2 was responsible for the resistance to all tested drugs, while the up-regulation of CAV1 only attenuated cell death mediated by doxorubicin and etoposide. Interestingly, NO-mediated drug resistance was found to be reversible when cells were further cultured in the absence of NO for five days. Conclusion: These findings reveal the novel role of NO in the tumor environment, in attenuating chemotherapeutic susceptibility and this could be beneficial in contriving strategies to treat the disease.

KW - Chemotherapeutic resistance

KW - Cisplatin

KW - Doxorubicin

KW - Etoposide

KW - Lung cancer

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=84891421503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891421503&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84891421503

VL - 33

SP - 5433

EP - 5444

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 12

ER -